and Bcl-2, Bcl-XL down regulation, causing AIF and cytochrome c release. Curcumin is currently undergoing phase II/III clinical trials in different types of cancer, including colon and cervical cancers, with promising results in some Cases.
Sanguinarine, a natural benzylisoquinoline alkaloid, interferes with mitochondrial calcium loading capacity and causes an increase in p53 expression. It was reported that complex II is a mitochondrial target for Sanguinarine, which may explain the effects on the respiration. Other studies confirmed that Sanguinarine causes apoptosis via mitochondrial depolarization and cytochrome c release, ROSinduced DNA damage, glutathione depletion, and cleavage of poly (ADP-ribose) polymerase and β-catenin. Berberine, an alkaloid derived from plants of the Berberidaceae family, has also been described to act as an anticancer agent, exerting several direct effects on mitochondria function, including inhibition of mitochondrial complex I and interaction with the ANT.
Mitochondrial alterations in the context of metabolic reprogramming in cancer cells are attractive targets for a novel therapeutic approach. However, there are still many obstacles to a full application of this approach. Not only it is important to identify the specific mitochondrial alteration in each tumor type for better therapeutic achievement but it is also critical to understand how untargeted tissues are affected by these new therapies. As described in this article, there are natural compounds with the specific potential of targeting tumor mitochondria and act as mitocans. Although only a few of these compounds move to subsequent clinical trials. Also, mitochondria have key roles in both cell life and death, which makes a challenge to selectively targeting of mitochondria abnormalities in tumor cells without any functional consequence for their normal counterparts. However, there are no extremely effective drugs to treat most cancers. There is a general call for new drugs that are highly effective, possess low toxicity, and have a minor environmental impact. Novel natural products offer opportunities for cancer therapy. For best effect and low toxicity, mitochondrial changes in cancer cells can be new potential targets for efficient and selective anti-cancer therapy. 
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